NVIDIA and Lilly are putting together “a blueprint for what is possible in the future of drug discovery,” NVIDIA founder and CEO Jensen Huang told attendees at a fireside chat Monday with Dave Ricks, chair and CEO of Lilly. The conversation — which took place during the annual J.P. Morgan Healthcare Conference in San Francisco Read Article
News Archive
Browse historical AI news items (30+ days old)